Previous Page  53 / 60 Next Page
Information
Show Menu
Previous Page 53 / 60 Next Page
Page Background

HIPERTENSIÓN / 2014 / VOL. 19

51

Mensajes finales

Es necesario mencionar que el control médico de los hipertensos no es sólo controlar cifras de

presión, sino que se debe persistentemente buscar daño de órganos “blanco”, que finalmente

es el que dará el pronóstico de estos pacientes.

Bibliografía

1.

Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home,and ambulatory

blood pressure. Hypertension. 2006;47:846-53

2..

Pickering GT. The ninth Sir George Pickering memorial lectura ambulatory monitoring and the definition of hypertension. J Hypertens. 1992;10:401-9

3.

Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal

office blood pressure. Ann Intern Med. 1999;131:564-72

4.

Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension.

2005;45:493-8

5.

Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of masked hypertension detected by blood pressure self-measurement

in elderly treated hypertensive patients. JAMA. 2004;291:1342-9

6.

Sobrino J, Domenech M, Camafort M, Vinyoles E, Coca A; ESTHEN group investigators Prevalence of masked hypertension and associated factors in normotensive

healthcare workers. Blood Press Monit. 2013;18(6):326-31

7.

Verberk WJ, Kessels AG, De Leeuw PW. Prevalence, causes, and consequences of masked hypertension: a meta-analysis. Am J Hypertens. 2008;21:969-75

8.

Sobrino J, Domenech M, Camafort M, Vinyoles E, Coca A; investigadores del grupo ESTHEN. Prevalence of masked hypertension in a cohort of controlled

hypertensive patients in Spain]. Med Clin (Barc). 2011;136(14):607-12.

9.

Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring:

is it the same phenomenon? Am J Hypertens. 2005;18:772-8

10.

Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens. 2008;26:1715-25

11.

Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. In clinical practice, masked hypertension is as common as isolated clinic hypertension: predominance of younger

men. Am J Hypertens. 2005;18:589-93

12.

Pierdomenico SD, Pannarale G, Rabbia F, Lapenna D, Licitra R, Zito M, et al. Prognostic relevance of masked hypertension in subjects with prehypertension.

Am J Hypertens. 2008;21:879-83

13

Cuspidi C, Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, et al. Isolated ambulatory hypertension and changes in target organ damage intreated hypertensive

patients. J Hum Hypertens. 2005;19:471-7

14.

Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S, et al. Masked hypertension and target organ damage in treated hypertensive patients. Am

J Hypertens. 2006;19:880-6

15.

Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of masked hypertension and white-coat hypertension detected by 24-h

ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508-15

16.

Hansen TW, Kikuya M, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, et al. IDACO Investigators. Prognostic superiority of daytime ambulatory over

conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens. 2007;25:1554-64

17.

Palatini P, Winnicki M, Santonastaso M, Mos L, Longo D, Zaetta V, et al. Prevalence and clinical significance of isolated ambulatory hypertension in young

subjects screened for stage 1 hypertension. Hypertension. 2004;44:170-4

18.

Kanno A, Metoki H, Kikuya M, Terawaki H, Hara A, Hashimoto T, et al.Usefulness of assessing masked and white-coat hypertension by ambulatory blood

pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study. Hypertens Res. 2010;33(11):1192-8.

19.

Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home

hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104:1385-92.

20.

Rasmussen SL, Torp-Pedersen C, Borch-Johnsen K, Ibsen H. Normal values for ambulatory blood pressure and differences between casual blood pressure and

ambulatory blood pressure: results from a Danish population survey. J Hypertens. 1998;16: 1415-24.